WHO ICTRP trial
The treatment of coronary artery lesions using the PRO-Kinetic energy…
NL-OMON43820 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON43820 |
|---|---|
| Public title | The treatment of coronary artery lesions using the PRO-Kinetic energy cobalt-chromium, bare-metal stent (BIOHELIX-I) |
| Scientific title | The treatment of coronary artery lesions using the PRO-Kinetic energy cobalt-chromium, bare-metal stent (BIOHELIX-I) - BIOHELIX-I |
| Primary sponsor | Biotronik |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | Canada;Germany;Netherlands ;United States of America |
| Conditions | coronary artery disease coronary lesions;10011082;coronary artery disease;coronary lesions |
| Interventions | Potential subjects will undergo CAD screening according to each investigative site*s standard of care. The medical history of individuals with CAD who qualify for a percutaneous coronary intervention (PCI) procedure will be evaluated and… |
| Registration date | Oct 20, 2016 |
| Target size | 50 |
| Secondary IDs | NCT01612767;NL42680.060.12 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: